Zol0h 0006 01
Zoledronic Acid
Product Images NDC 17478-327
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zoledronic Acid (NDC 17478-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Zol0h 0006 02
Zol0h 0006 03
This is a warning not to mix calcium-containing infusion solutions with the drug Zoledronic Acid manufactured by Akorn, Inc. The drug is contained in a single-dose vial that should be stored at a temperature of 25°C (77°F) and may be permitted to be stored between 15°C and 30°C (59°F to 86°F). The drug is a sterile concentrate and should only be administered after dilution. The text also indicates that the drug is not for direct injection. Information on concentration and manufacturing location is also provided.*
Zol0h 0006 04
Zoledronic Acid Injection is a sterile concentrate meant for intravenous infusion after dilution. The single-dose vial contains 4mg/5mL (0.8mg/mL) of the drug. It is important to note that the dose must be diluted and not for direct injection. Users are advised to see the package insert for the preparation of the solution and not to mix the drug with calcium-containing infusion solutions. The National Drug Code (NDC) for the injection is 17478-327-05.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
